A detailed history of Portman Square Capital LLP transactions in Conmed Corp stock. As of the latest transaction made, Portman Square Capital LLP holds 15,800 shares of CNMD stock, worth $1.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
15,800
Previous 100,000 84.2%
Holding current value
$1.2 Million
Previous $6.93 Million 83.61%
% of portfolio
0.05%
Previous 0.25%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$64.09 - $76.92 $1.18 Million - $1.41 Million
18,347 New
18,347 $1.32 Million
Q4 2023

Jan 19, 2024

SELL
$91.3 - $115.05 $1.63 Million - $2.05 Million
-17,853 Reduced 67.57%
8,568 $938,000
Q3 2023

Oct 30, 2023

BUY
$97.55 - $135.91 $156,860 - $218,543
1,608 Added 6.48%
26,421 $2.66 Million
Q1 2023

May 04, 2023

BUY
$89.75 - $107.27 $1.14 Million - $1.36 Million
12,721 Added 105.2%
24,813 $2.58 Million
Q4 2022

Feb 23, 2023

BUY
$72.84 - $94.04 $880,781 - $1.14 Million
12,092 New
12,092 $1.07 Billion

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.31B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Portman Square Capital LLP Portfolio

Follow Portman Square Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portman Square Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Portman Square Capital LLP with notifications on news.